Inventor · disambiguated record
Christopher Thomson
Also filed as: THOMSON CHRISTOPHER · THOMSON CHRISTOPHER G · THOMSON CHRISTOPHER GEORGE
15 granted patents·10 pending applications·44 citations·filing 1998–2025
88Inventor score
Top patents by PatentIndex Score
25 records- 0190US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0289US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0377US8546416B23-spirocyclic piperidine derivatives as ghrelin receptor agonistsAMBARKHANE AMEET VIJAY·Filed 2012·Granted Oct 1, 2013·8 cites·11 claims
- 0477US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0574US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 0670US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 0768US9763957B2Autotaxin inhibitorsNOVARTIS AG·Filed 2014·Granted Sep 19, 2017·1 cites·7 claims
- 0868US9630945B2Autotaxin inhibitorsFURMINGER VIKKI·Filed 2013·Granted Apr 25, 2017·4 cites·4 claims
- 0966US2025313524A1Pi3k-alpha inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1065US6555552B2Azabicyclic amine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 2002·Granted Apr 29, 2003·3 cites·19 claims
- 1165US6225320B1Spiro-azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1998·Granted May 1, 2001·24 cites·19 claims
- 1259US2024368122A1Jak2 inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1352US2024150345A1Gcn2 modulating compounds and uses thereofHIBERCELL INC·Filed 2022·Application pending·0 cites
- 1451US9751876B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionNOVARTIS AG·Filed 2014·Granted Sep 5, 2017·0 cites·18 claims
- 1551US2024083897A1Gcn2 modulating compounds and uses thereofHIBERCELL INC·Filed 2022·Application pending·0 cites
- 1649US2025179028A1Acrylamide compoundsNRG THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1748US12491185B2Inhibitors of mPTPNRG THERAPEUTICS LTD·Filed 2025·Granted Dec 9, 2025·0 cites·30 claims
- 1846US10183025B2Autotaxin inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 22, 2019·0 cites·5 claims
- 1945US8883819B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionBRUCE IAN·Filed 2012·Granted Nov 11, 2014·0 cites·20 claims
- 2045US8163956B2Inhibitors of GLYT1 transportersBLACKABY WESLEY PETER·Filed 2006·Granted Apr 24, 2012·0 cites·11 claims
- 2144US2016168119A1Autotaxin inhibitorsBAETTIG URS·Filed 2014·Application pending·0 cites
- 2242US2013331369A13-Spirocyclic Piperidine Derivatives as Ghrelin Receptor AgonistsAMBARKHANE AMEET VIJAY·Filed 2013·Application pending·0 cites
- 2341US9409895B2Autotaxin inhibitorsLEGRAND DARREN MARK·Filed 2013·Granted Aug 9, 2016·0 cites·11 claims
- 2434US2017007614A1Autotaxin inhibitorsLEGRAND DARREN MARK·Filed 2016·Application pending·0 cites
- 2524US2017037030A1Autotaxin inhibitorsFURMINGER VIKKI·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Thomson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →